Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Trace Amine-Associated Receptor 1 (TAAR1): A new drug target for psychiatry? — Seetal Dodd (2020) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Trace Amine-Associated Receptor 1 (TAAR1): A new drug target for psychiatry?
Shared by
Michael Maes
University of Electronic Science and Technology of China
Trace Amine-Associated Receptor 1 (TAAR1): A new drug target for psychiatry?
Article
2020
en
Authors
+4 more
SD
Seetal Dodd
AC
André F. Carvalho
BP
Basant K. Puri
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2025
Natural variability of trace-amine associated receptors in wild meerkats
Johannes Fähnle
,
Kerstin Wilhelm
,
Benedikt Wiese
,
Marta B. Manser
,
Tim Clutton-brock
,
Simone Sommer
,
Nadine Müller‐Klein
Article
2015
The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue
Kurt Lucas
,
Gerwyn Morris
,
George Anderson
,
Michael Maes
Article
2010
TSG101: A Novel Anti-HIV-1 Drug Target
Hongfei Chen
,
Xinyong Liu
,
Zhenyu Li
,
Peng Zhan
,
De Clercq Erik
Letter
2022
Chemokine receptor CCR1: new target for asthma therapy
Peter J Barnes
Article
2004
The amino acid N136 in HIV-1 reverse transcriptase qualifies as a target for new (NNRTI) drug design
Jan Balzarini
,
Johan Auwerx
,
Fátima Rodrı́guez-Barrios
,
Francesca Ceccherini‐Silberstein
,
Carlos Garcı́a-Aparicio
,
Sonsoles Velázquez
,
De Clercq Erik
,
Carlo Federico Perno
,
Marı́a-José Camarasa
,
Federico Gago
Discussion(0)
No comments yet. Be the first to comment.